Transient receptor potential vanilloid 2 (TRPV2), a potential novel biomarker in childhood asthma

Journal of Asthma

Volumn 50, Issue 2, 2013, Pages 209-214

  Cai, Xin ^a   Yang, Yong Chang ^c   Wang, Jing Feng ^a   Wang, Qiang ^b   Gao, Jie ^a   Fu, Wen Liang ^a   Zhu, Ze Yi ^a   Wang, Yuan Yuan ^a   Zou, Min Ji ^a   Wang, Jia Xi ^a   Xu, Dong Qun ^b   Xu, Dong Gang ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Biomarker; Case control cohort; Childhood asthma; Gene expression; Transient receptor potential vanilloid 2 (TRPV2)

Indexed keywords

HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; POLLEN ANTIGEN; VANILLOID RECEPTOR 2;

ALLERGIC ASTHMA; ARTICLE; ASTHMA; BLOOD SAMPLING; CASE CONTROL STUDY; CAT; CHILD; COCKROACH; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DOG; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MOULD; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PERIPHERAL LYMPHOCYTE; PRESCHOOL CHILD; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SCHOOL CHILD; SENSITIZATION; UPREGULATION; WHEEZING;

ALLERGENS; ASTHMA; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHINA; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOGLOBULIN E; LEUKOCYTES, MONONUCLEAR; LOGISTIC MODELS; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TRPV CATION CHANNELS; URBAN POPULATION;

EID: 84873619111     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.3109/02770903.2012.753454     Document Type: Article

References (32)

1. Owayed A, Begbehani N, Al-Momen J. Changing prevalence of asthma and allergic diseases among Kuwaiti children. An ISAAC Study (Phase III). Med Princ Pract 2008; 17:284-289
2. Lemanske RF Jr, Busse WW. Asthma. J Allergy Clin Immunol 2003; 111:S502-S519
3. Tattersfield AE, Knox AJ, Britton JR, Hall IP. Asthma. Lancet 2002; 360:1313-1322
4. Parameswaran K, Janssen LJ, O'Byrne PM. Airway hyperresponsiveness and calcium handling by smooth muscle. Chest 2002; 121:621-624
5. Lemanske RF Jr, Busse WW. Asthma: Factors underlying inception, exacerbation, and disease progression. J Allergy Clin Immunol 2006; 117:S456-S461
6. Murray CS, Poletti G, Kebadze T, Morris J, Woodcock A, Johnston SL, Custovic A. Study of modifiable risk factors for asthma exacerbations: Virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax 2006; 61:376-382
7. Green RM, Custovic A, Sanderson G, Hunter J, Johnston SL, Woodcock A. Synergism between allergens and viruses and risk of hospital admission with asthma: Case-control study. BMJ 2002; 324:763-768
8. Hdud IM, El-Shafei AA, Loughna P, Barrett-Jolley R, Mobasheri A. Expression of Transient Receptor Potential Vanilloid (TRPV) channels in different passages of articular chondrocytes. Int J Mol Sci. 2012; 13:4433-4445
9. Nilius B, Owsianik G, Voets T, Peters JA. Transient receptor potential cation channels in disease. Physiol Rev 2007; 87:165-217
10. Nilius, B.; Owsianik, G. The transient receptor potential family of ion channels. Genome Biol. 2011;12:218
11. Nelson, P.L.; Beck, A.; Cheng, H. Transient receptor proteins illuminated: Current views on TRPs and disease. Vet J 2010; 187:153-164
12. Vennekens R, Owsianik G, Nilius B. Vanilloid transient receptor potential cation channels: An overview. Curr Pharm Des 2008; 14:18-31
13. Colsoul B, Nilius B, Vennekens R: On the putative role of transient receptor potential cation channels in asthma. Clin Exp Allergy 2009; 39:1456-1466
14. Valverde MA, Cantero-Recasens G, Garcia-Elias A, Jung C, Carreras A, Vicente R. Ion channels and asthma. J Biol Chem. 2011; 286:32877-32882
15. Groneberg DA, Niimi A, Dinh QT, Cosio B, Hew M, Fischer A, Chung KF: Increased expression of transient receptor potential vanilloid-1 in airway nerves of chronic cough. Am J Respir Crit Care Med. 2004; 170:1276-1280
16. Mitchell JE, Campbell AP, New NE, Sadofsky LR, Kastelik JA, Mulrennan SA, Compton SJ, Morice AH. Expression and characterization of the intracellular vanilloid receptor (TRPV1) in bronchi from patients with chronic cough. Exp Lung Res 2005; 31:295-306
17. Iwata Y, Katanosaka Y, Arai Y, Komamura K, Miyatake K, Shigekawa M. A novel mechanism of myocyte degeneration involving the Ca2-permeable growth factor-regulated channel. J Cell Biol. 2003; 161:957-967
18. Muraki K, Iwata Y, Katanosaka Y, Ito T, Ohya S, Shigekawa M, Imaizumi Y. TRPV2 is a component of osmotically sensitive cation channels in murine aortic myocytes. Circ Res 2003; 93:829-838
19. Banner KH, Igney F, Poll C. TRP channels: Emerging targets for respiratory disease. Pharmacol Ther 2011; 130:371-384
20. Kim KS, Shin DH, Nam JH, Park KS, Zhang YH, Kim WK, Kim SJ. Functional expression of TRPV4 cation channels in human mast cell line (HMC-1). Korean J Physiol Pharmacol 2010; 14(6):419-425
21. Yang XR, Lin MJ, McIntosh LS, Sham JS. Functional expression of transient receptor potential melastatin-and vanilloid-related channels in pulmonary arterial and aortic smooth muscle. Am J Physiol Lung Cell Mol Physiol 2006; 290:L1267-L1276
22. Saunders CI, Kunde DA, Crawford A, Geraghty DP. Expression of transient receptor potential vanilloid 1 (TRPV1) and 2 (TRPV2) in human peripheral blood. Mol Immunol. 2007; 44:1429-1435
23. Simpson A, Tan VY, Winn J, Svensén M, Bishop CM, Heckerman DE, Buchan I, Custovic A. Beyond atopy: Multiple patterns of sensitization in relation to asthma in a birth cohort study. Am J Respir Crit Care Med. 2010; 181:1200-1206
24. Johansson SG, Hourihane JO, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, Kowalski ML, Mygind N, Ring J, van Cauwenberge P, van Hage-Hamsten M, Wüthrich B; EAACI (the European Academy of Allergology and Cinical Immunology) Nomenclature Task Force.Arevised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001; 56:813-824
25. Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, Motala C, Ortega Martell JA, Platts-Mills TA, Ring J, Thien F, Van Cauwenberge P, Williams HC. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization. J Allergy Clin Immunol. 2004; 113:832-836
26. Atkins D, Leung DYM. Diagnosis of allergic disease. In: Behrman RE, Kliegman RM, Jenson HB, eds. Nelson Textbook of Pediatrics, 17 ed. Philadelphia, PA: WB Saunders, 2004: 747-751
27. Ji RR, Samad TA, Jin SX, Schmoll R, Woolf CJ. p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron. 2002; 36:57-68
28. Chu C, Zavala K, Fahimi A, Lee J, Xue Q, Eilers H, Schumacher MA. Transcription factors Sp1 and Sp4 regulate TRPV1 gene expression in rat sensory neurons. Mol Pain 2011; 7:44
29. Lee LY, Gu Q. Role of TRPV1 in inflammation-induced airway hypersensitivity. Curr Opin Pharmacol 2009; 9:243-249
30. Gu Q, Lee LY. Airway irritation and cough evoked by acid: From human to ion channel. Curr Opin Pharmacol 2011; 11:238-247
31. Bonini S, Lambiase A, Bonini S, Angelucci F, Magrini L, Manni L, Aloe L. Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma. Proc Natl Acad Sci USA 1996; 93:10955-10960
32. Boukalova S, Marsakova L, Teisinger J, Vlachova V. Conserved residues within the putative S4-S5 region serve distinct functions among thermosensitive vanilloid transient receptor potential (TRPV) channels. J Biol Chem 2010; 285(53):41455-41462.